Keywords: genzyme/isis, begin, mipomersen, trials, biotechnology, major, genzyme

Genzyme/Isis begin three mipomersen trials

Article | 19 January 2009

Biotechnology major Genzyme and fellow USA-based Isis Pharmaceuticals have begun two new late-stage studies of mipomersen in hypercholesterolemia patients, with ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Genzyme

Isis Pharmaceuticals

Go to company listing